Scientific Programme
The 20th Annual ENETS Conference
22 - 24 March 2023
Vienna, Austria
13th Annual ENETS Postgraduate Course
Wednesday, 22 March 2023
REGISTRATION & COFFEE
Time: Wednesday 08:00 - 08:45
Room: Entrance Hall
Welcome and opening - 20th Annual ENETS Conference
Time: Wednesday 08:45 - 08:50
Room: Hall E
Moderators:
Eva Tiensuu Janson, SWE
Opening & overview - 13th Annual ENETS Postgraduate Course
Time: Wednesday 08:50 - 09:00
Room: Hall E
Moderators:
Eric Baudin, FRA / Christos Toumpanakis, GBR
Session A: Diagnostic challenges & dilemmas in NEN medicine
Time: Wednesday 09:00 - 10:30
Room: Hall E
Moderators:
Beata Kos-Kudła, POL / John Ramage, GBR
| 09:00 - 09:06 | Are we sure that it is a NEN? The importance of histopathology review by a NEN expert pathologist
|
| Aurel Perren, SUI |
| 09:06 - 09:10 | Discussion
|
| Assessment of disease progression: “Tips and traps” | (09:10 - 09:40) |
| 09:10 - 09:16 | NET biomarkers: How do I interpret 5HIAA/Chromogranin A increase in small intestinal NET?
|
| Staffan Welin, SWE |
| 09:16 - 09:20 | Discussion
|
| 09:20 - 09:32 | Imaging (cross-sectional and molecular): How do I interpret RECIST, non-RECIST progression, and PERCIST progression?
|
| Clarisse Dromain, SUI / Anja Rinke, GER |
| 09:32 - 09:40 | Discussion
|
| 09:40 - 09:46 | FDG-avid lesion: Any robust implications to patients’ management?
|
| Valentina Ambrosini, ITA |
| 09:46 - 09:50 | Discussion
|
| 09:50 - 09:56 | Should I re-biopsy during the course of the disease?
|
| Martyn Caplin, GBR |
| 09:56 - 10:00 | Discussion
|
| 10:00 - 10:30 | Panel discussion
|
COFFEE BREAK
Time: Wednesday 10:30 - 11:00
Room: Entrance Hall
Session B: Therapeutic challenges and dilemmas in NEN medicine
Time: Wednesday 11:00 - 12:30
Room: Hall E
Moderators:
Els Nieveen van Dijkum, NED / Marianne Pavel, GER
| 11:00 - 11:10 | Optimal surgical approach to avoid short and long-term complications in localised small bowel and pancreatic NET
|
| Detlef Bartsch, GER |
| 11:10 - 11:15 | Discussion
|
| 11:15 - 11:25 | Systemic NET treatments in populations with co-morbidities: What is different?
|
| Nicola Fazio, ITA |
| 11:25 - 11:30 | Discussion
|
| 11:30 - 11:40 | Systemic treatments’ rechallenge: Is it really beneficial?
|
| Enrique Grande, ESP |
| 11:40 - 11:45 | Discussion
|
| 11:45 - 11:55 | Is there any best sequence in localized NEC treatment?
|
| Anna Koumarianou, GRE |
| 11:55 - 12:00 | Discussion
|
| 12:00 - 12:30 | Panel discussion
|
LUNCH BREAK
Time: Wednesday 12:30 - 14:00
Room: Entrance Hall
Session C: NET difficult scenarios
Time: Wednesday 14:00 - 15:30
Room: Hall E
Moderators:
Kjell Öberg, SWE / Anja Rinke, GER
| 14:00 - 14:10 | NET emergencies: Hormonal crises
|
| Gregory Kaltsas, GRE |
| 14:10 - 14:15 | Discussion
|
| 14:15 - 14:25 | Mesenteric fibrosis: Best management of its complications
|
| Hans Hofland, NED |
| 14:25 - 14:30 | Discussion
|
| 14:30 - 14:40 | NET bone metastases: Systemic management
|
| Julien Hadoux, FRA |
| 14:40 - 14:45 | Discussion
|
| 14:45 - 14:55 | Nutrition support in advanced NETs
|
| Dominique Clement, GBR |
| 14:55 - 15:00 | Discussion
|
| 15:00 - 15:30 | Panel discussion
|
COFFEE BREAK
Time: Wednesday 15:30 - 16:00
Room: Entrance Hall
Session D: Becoming familiar with new ENETS Guidance Papers through an MDT approach (Panel Discussion)
Time: Wednesday 16:00 - 17:30
Room: Hall E
Moderators:
Rocio Garcia-Carbonero, ESP / Christos Toumpanakis, GBR
MDT panel: Pathologist: Marie-Louise van Velthuysen, NED | NM Physician: Christophe Deroose, BEL | Surgeon: Ulrich Knigge, DEN | Gastroenterologist: Francesco Panzuto, ITA | Oncologist: Margot Tesselaar, NED | Endocrinologist: Beata Kos-Kudła, POL | NET Specialist Nurse: Wendy Martin, GBR
| 16:00 - 16:30 | Case 1: Metastatic small bowel NET with carcinoid syndrome and carcinoid heart disease
|
| Christos Toumpanakis, GBR |
| 16:30 - 17:00 | Case 2: Functioning pNETs
|
| Antongiulio Faggiano, ITA |
| 17:00 - 17:15 | Case 3: When right hemicolectomy is needed in appendiceal NET: Evolving data and controversies in management and follow-up
|
| Gregory Kaltsas, GRE |
| 17:15 - 17:30 | Case 4: Small type III gastric NET treated by endoscopic resection
|
| Francesco Panzuto, ITA |
Closing comments - 13th Annual ENETS Postgraduate Course
Time: Wednesday 17:30 - 17:40
Room: Hall E
Moderators:
Eric Baudin, FRA / Christos Toumpanakis, GBR
ENETS projects
Time: Wednesday 17:40 - 17:50
Room: Hall E
Moderators:
Eva Tiensuu Janson, SWE
Welcome reception
Time: Wednesday 18:00 - 19:00
Room: Entrance Hall
1st ENETS Basic and Translational NET Research – A Forum on Basic and Translational Science in Neuroendocrine Neoplasms
Wednesday, 22 March 2023
REGISTRATION & COFFEE
Time: Wednesday 08:00 - 08:45
Room: Entrance Hall
Welcome and opening - 20th Annual ENETS Conference (livestream from Hall E)
Time: Wednesday 08:45 - 08:50
Room: Hall F
Moderators:
Eva Tiensuu Janson, SWE
Welcome - 1st ENETS basic and translational NET research forum
Time: Wednesday 08:50 - 09:00
Room: Hall F
Moderators:
Justo P. Castaño, ESP / Anne Couvelard, FRA
Session 1
Time: Wednesday 09:00 - 10:30
Room: Hall F
Moderators:
Justo P. Castaño, ESP / Stefano La Rosa, ITA
| 09:00 - 09:25 | Single-nucleus and in situ RNA-sequencing reveal cell topographies in the human pancreas (Keynote speech)
|
| Christian Conrad, GER |
| 09:25 - 09:30 | Discussion
|
| 09:30 - 09:45 | Recent molecular classifications of lung NENs: Where are we?
|
| Lynnette Fernandez-Cuesta, FRA |
| 09:45 - 09:50 | Discussion
|
| 09:50 - 10:05 | The single-cell transcriptional landscape of lung carcinoid tumors
|
| Philip Bischoff, GER |
| 10:05 - 10:10 | Discussion
|
| 10:10 - 10:17 | Abstract presentation: The lungNENomics project – A comprehensive multidisciplinary characterisation of pulmonary carcinoids
|
| Matthieu Foll, FRA |
| 10:17 - 10:20 | Discussion
|
| 10:20 - 10:27 | Abstract presentation: Transcriptomic analyses of multifocal ileal neuroendocrine tumors
|
| Netta Mäkinen, USA |
| 10:27 - 10:30 | Discussion
|
COFFEE BREAK
Time: Wednesday 10:30 - 11:00
Room: Entrance Hall
Session 2
Time: Wednesday 11:00 - 12:30
Room: Hall F
Moderators:
Anne Couvelard, FRA / Bertram Wiedenmann, GER
| 11:00 - 11:15 | Roles and mechanisms of alternative splicing in cancer - implications for care
|
| Justo P. Castaño, ESP |
| 11:15 - 11:20 | Discussion
|
| 11:20 - 11:27 | Abstract presentation: Subtype-specific landscape of splicing-associated neoantigens and mutations in pancreatic neuroendocrine tumors
|
| Anguraj Sadanandam, GBR |
| 11:27 - 11:30 | Discussion
|
| 11:30 - 11:45 | Cancer stem cells, immunotherapy and the importance of the microenvironment in pancreatic cancer and NENs
|
| Bruno Sainz Anding, ESP |
| 11:45 - 11:50 | Discussion
|
| 11:50 - 11:57 | Abstract presentation: Molecular landscape of splicing dysregulation in pheochromocytomas and paragangliomas
|
| María Trinidad Moreno-Montilla, ESP |
| 11:57 - 12:00 | Discussion
|
| 12:00 - 12:30 | Panel discussion
|
LUNCH BREAK
Time: Wednesday 12:30 - 14:00
Room: Entrance Hall
Session 3
Time: Wednesday 14:00 - 15:30
Room: Hall F
Moderators:
Joakim Crona, SWE / Guido Rindi, ITA
| 14:00 - 14:25 | A pan-tissue DNA methylation atlas enables in silico decomposition of human tissue methylomes at cell-type resolution (Keynote speech)
|
| Chrissie Thirlwell, GBR |
| 14:25 - 14:40 | Epigenetics in NENs, role in oncogenesis and clinical potential
|
| Ilaria Marinoni, SUI |
| 14:40 - 14:47 | Abstract presentation: The effect of pseudohypoxia on the immune microenvironment of pancreatic neuroendocrine neoplasms (PanNEN)
|
| Amit Tirosh, ISR |
| 14:47 - 15:00 | Discussion
|
| 15:00 - 15:15 | Temozolomide and NETs: Friends or foes?
|
| Jérôme Cros, FRA |
| 15:15 - 15:22 | Abstract presentation: Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine cancer
|
| Talya Dayton, ESP |
| 15:22 - 15:30 | Discussion
|
COFFEE BREAK
Time: Wednesday 15:30 - 16:00
Room: Entrance Hall
Session 4
Time: Wednesday 16:00 - 17:30
Room: Hall F
Moderators:
Jaume Capdevila, ESP / Eva Tiensuu Janson, SWE
| 16:00 - 16:15 | The molecular landscape of high-grade gastroenteropancreatic NEN
|
| Halfdan Sorbye, NOR |
| 16:15 - 16:20 | Discussion
|
| 16:20 - 16:27 | Abstract presentation: Germline whole-exome sequencing of patients with neuroendocrine neoplasms reveals pathogenic or likely pathogenic variants in a large subset of patients
|
| Vineeth Sukrithan, USA |
| 16:27 - 16:30 | Discussion
|
| 16:30 - 16:45 | ALT-ered NENs: role and value of DAXX/TRX alterations to understand NEN pathology and disease prognosis
|
| Rita Lawlor, ITA |
| 16:45 - 16:50 | Discussion
|
| 16:50 - 16:57 | Abstract presentation: Multi-omic factor analysis (MOFA) of well-differentiated neuroendocrine tumors (NETs) from different tumor sites
|
| Carlos Carretero, ESP |
| 16:57 - 17:00 | Discussion
|
| 17:00 - 17:30 | Panel discussion
|
Closing comments - 1st ENETS basic and translational NET research forum
Time: Wednesday 17:30 - 17:40
Room: Hall F
Moderators:
Justo P. Castaño, ESP / Anne Couvelard, FRA
ENETS projects (livestream from hall E)
Time: Wednesday 17:40 - 17:50
Room: Hall F
Moderators:
Eva Tiensuu Janson, SWE
Welcome reception
Time: Wednesday 18:00 - 19:00
Room: Entrance Hall
20th Annual ENETS Conference
Thursday, 23 March 2023
Satellite Symposium - Industry-sponsored
Time: Thursday 07:45 - 08:45
Room: Hall F
Session 1: Interdisciplinary management of neuroendocrine tumor syndromes: Which tools for which goals ?
Time: Thursday 09:00 - 10:30
Room: Hall E
Moderators:
Francesco Panzuto, ITA / Staffan Welin, SWE
| 09:00 - 09:15 | Are functioning NET biologically distinct from non-functioning NET?
|
| Eric Baudin, FRA |
| 09:15 - 09:20 | Discussion
|
| 09:20 - 09:35 | Carcinoid syndrome
|
| Simona Glasberg, ISR |
| 09:35 - 09:40 | Discussion
|
| 09:40 - 09:55 | Ectopic Cushing syndrome
|
| Camilla Schalin-Jantti, FIN |
| 09:55 - 10:00 | Discussion
|
| 10:00 - 10:15 | Other/rare functioning pancreatic NET
|
| Wouter W. De Herder, NED |
| 10:15 - 10:20 | Discussion
|
| 10:20 - 10:27 | Abstract presentation: Glucagonomas – Characteristics and treatment options based on a French multicenter cohort study
|
| Marine Perrier, FRA |
| 10:27 - 10:30 | Discussion
|
COFFEE BREAK
Time: Thursday 10:30 - 11:00
Room: Entrance Hall
Session 2A: Theragnostics
Time: Thursday 11:00 - 12:20
Room: Hall E
Moderators:
Christophe Deroose, BEL / Nicola Fazio, ITA
| 11:00 - 11:30 | Theragnostics (Keynote speech)
|
| Andreas Kjaer, DEN |
| 11:30 - 11:37 | Abstract presentation: Tumor uptake on 18FDOPA PET/CT is a strong prognostic factor in patients with metastatic small intestine neuroendocrine tumors (siNETs) – A GTE study
|
| Louis de Mestier, FRA |
| 11:37 - 11:40 | Discussion
|
| 11:40 - 11:47 | Abstract presentation: A novel and potent Pb-212 alpha-particle therapy for NETs – Complete responses in mouse models to global clinical translation for NET patients
|
| Markus Puhlmann, USA |
| 11:47 - 11:50 | Discussion
|
| 11:50 - 11:57 | Abstract presentation: First report of the phase I LuPARP trial assessing 177Lu-DOTATATE in combination with the PARP inhibitor olaparib in patients with somatostatin positive tumors
|
| Andreas Hallqvist, SWE |
| 11:57 - 12:00 | Discussion
|
| 12:00 - 12:07 | Abstract presentation: Intra-arterial PRRT – A prospective clinical study in NET patients with hepatic metastases
|
| Sander Ebbers, NED |
| 12:07 - 12:10 | Discussion
|
| 12:10 - 12:17 | Abstract presentation: Imaging surveillance in multiple endocrine neoplasia type 1 – 10 years of experience with somatostatin receptor positron emission tomography
|
| Mikkel Andreassen, DEN |
| 12:17 - 12:20 | Discussion
|
Session 2B: INCA/ENETS Symposium: Working together to improve patient outcomes
Time: Thursday 11:00 - 12:00
Room: Hall F
Moderators:
Mark McDonnell, IRL / Eva Tiensuu Janson, SWE
| 11:00 - 11:02 | Welcome and introductions from ENETS/INCA
|
| Mark McDonnell, IRL / Eva Tiensuu Janson, SWE |
| 11:02 - 11:14 | Educating the Non-NEN physicians: ‘Think NENs’ educational program for GPs
|
| Sugandha Dureja, IND / Dermot O'Toole, IRL |
| 11:14 - 11:29 | The optimal NEN patient pathway – From Aspiration to reality
|
| Catherine Bouvier Ellis, GBR / Rocio Garcia-Carbonero, ESP / Teodora Kolarova, BUL |
| 11:29 - 11:42 | The instrumental role of patient input in research design
|
| Stephanie Alband, USA / Simron Singh, CAN |
| 11:42 - 11:57 | Q & A
|
| 11:57 - 12:00 | Wrap-up and close
|
| Mark McDonnell, IRL / Eva Tiensuu Janson, SWE |
LUNCH BREAK
Time: Thursday 12:30 - 14:00
Room: Entrance Hall
Satellite Symposium - Industry-sponsored
Time: Thursday 12:30 - 14:00
Room: Hall F
Session 3A: Joint ENETS-ESR Session
Time: Thursday 14:00 - 15:10
Room: Hall E
Moderators:
Clarisse Dromain, SUI / Marius Mayerhoefer, USA
| 14:00 - 14:25 | Limitations of RECIST for neuroendocrine therapy monitoring
|
| Damiano Caruso, ITA |
| 14:25 - 14:50 | Tumor Growth Rate (TGR) for neuroendocrine therapy monitoring
|
| Angela Lamarca, ESP |
| 14:50 - 15:10 | Panel discussion
|
Session 3B: Clinical abstract session
Time: Thursday 14:00 - 15:00
Room: Hall F
Moderators:
Rocio Garcia-Carbonero, ESP / Eva Tiensuu Janson, SWE
| 14:00 - 14:07 | OTP, CD44, and Ki-67 – A prognostic marker panel for relapse free survival in patients with surgically resected pulmonary carcinoid
|
| Laura Moonen, NED |
| 14:07 - 14:10 | Discussion
|
| 14:10 - 14:17 | Cabozantinib in high grade neuroendocrine neoplasms – Interim results from a Phase II trial
|
| Nikolaos Trikalinos, USA |
| 14:17 - 14:20 | Discussion
|
| 14:20 - 14:27 | Subgroup analysis of ORR and PFS of the SEQTOR study (GETNE 1206) – Everolimus followed by Streptozotocin (STZ)-5FU upon progression or the reverse sequence, in advanced progressive panNETs
|
| Jaume Capdevila, ESP |
| 14:27 - 14:30 | Discussion
|
| 14:30 - 14:37 | Long-term outcomes of surgical valve replacement in patients with severe carcinoid heart disease
|
| Aimee Hayes, GBR |
| 14:37 - 14:40 | Discussion
|
| 14:40 - 14:47 | Treatment efficacy in 212 metastatic small intestinal neuroendocrine tumor grade 2 patients
|
| Dimitrios Papantoniou, SWE |
| 14:47 - 14:50 | Discussion
|
| 14:50 - 14:57 | Clinical and morphogenetic features of renal neuroendocrine tumors
|
| Atsuko Kasajima, GER |
| 14:57 - 15:00 | Discussion
|
Life Achievement Award
Time: Thursday 15:10 - 15:30
Room: Hall E
Moderators:
Eva Tiensuu Janson, SWE
| 15:10 - 15:20 | Laudatio
|
| Frediano Inzani, ITA |
| 15:20 - 15:30 | Recipient and keynote address
|
| Guido Rindi, ITA |
COFFEE BREAK
Time: Thursday 15:30 - 16:00
Room: Entrance Hall
Session 4A: Mixed neuroendocrine – non-neuroendocrine neoplasms
Time: Thursday 16:00 - 17:10
Room: Hall E
Moderators:
Halfdan Sorbye, NOR / Marie-Louise van Velthuysen, NED
| 16:00 - 16:15 | Mixed NE- non-NE neoplasms in different organs: Definitions, concepts, and challenges
|
| Stefano La Rosa, ITA |
| 16:15 - 16:20 | Discussion
|
| 16:20 - 16:35 | How to treat mixed NEN?
|
| Francesca Spada, ITA |
| 16:35 - 16:40 | Discussion
|
| 16:40 - 16:55 | A clinico-pathological case of digestive MiNEN
|
| Melissa Frizziero, GBR |
| 16:55 - 17:10 | Panel discussion
|
Session 4B: Nutritional aspects of NET
Time: Thursday 17:10 - 17:30
Room: Hall E
Moderators:
Halfdan Sorbye, NOR / Marie-Louise van Velthuysen, NED
| 17:10 - 17:17 | Abstract presentation: Nutritional status of patients with advanced gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) in Spain – NUTRIGETNE study
|
| Maribel Del Olmo Garcia, ESP |
| 17:17 - 17:20 | Discussion
|
| 17:20 - 17:27 | Abstract presentation: Real-world data regarding the obesity paradox in patients with gastroenteropancreatic (GEP) NENs in a single centre in the United Kingdom
|
| Dominique Clement, GBR |
| 17:27 - 17:30 | Discussion
|
Session 4C: Bronchial and thymic NET
Time: Thursday 16:00 - 17:30
Room: Hall F
Moderators:
Eric Baudin, FRA / Anne-Marie Dingemans, NED
| 16:00 - 16:10 | Biology of bronchial and thymic carcinoids: What is clinically relevant?
|
| Anne-Marie Dingemans, NED |
| 16:10 - 16:15 | Discussion
|
| 16:15 - 16:25 | How to perform an RO resection in bronchial and thymic carcinoids?
|
| Pier Luigi Filosso, ITA |
| 16:25 - 16:30 | Discussion
|
| 16:30 - 16:40 | Locoregional management: When and how? (Focus on lung, pleura, and bone)
|
| Frederic Deschamps, FRA |
| 16:40 - 16:45 | Discussion
|
| 16:45 - 16:55 | Updates in the management of advanced bronchial and thymic carcinoids
|
| Jaume Capdevila, ESP |
| 16:55 - 17:00 | Discussion
|
| 17:00 - 17:07 | Abstract presentation: Protein validation of multi-omic classified pulmonary carcinoid – Identification of unique clinical subtypes and potential therapeutic vulnerability
|
| Jules Derks, NED |
| 17:07 - 17:10 | Discussion
|
| 17:00 - 17:07 | Abstract presentation: Surgery of primary lung carcinoid tumors at metastatic stage – A national study from the French Group of Endocrine Tumors (GTE) and ENDOCAN-RENATEN network
|
| Thomas Walter, FRA |
| 17:17 - 17:20 | Discussion
|
| 17:00 - 17:07 | Abstract presentation: R-ache-L score – A nomogram model for predicting prognosis of lung neuroendocrine tumors according to primary tumor side
|
| Anna La Salvia, ITA |
| 17:27 - 17:30 | Discussion
|
Satellite Symposium - Industry-sponsored
Time: Thursday 17:45 - 19:15
Room: Hall F
Friday, 24 March 2023
Session 5A: New developments in systemic therapy of NEN
Time: Friday 09:00 - 10:30
Room: Hall E
Moderators:
Marianne Pavel, GER / Philippe Ruszniewski, FRA
| 09:00 - 09:15 | Where is the place of angiogenesis inhibitors in the treatment algorithm of NEN?
|
| Marianne Pavel, GER |
| 09:15 - 09:20 | Discussion
|
| 09:20 - 09:35 | New avenues for immunotherapy: Combinations and beyond…
|
| Daniel M. Halperin, USA |
| 09:35 - 09:50 | Can systemic therapy improve PRRT efficacy?
|
| Damian Wild, SUI |
| 09:50 - 10:05 | New targets and potential agents directed to NEN therapy
|
| Christoph J. Auernhammer, GER |
| 10:05 - 10:20 | Panel discussion
|
| 10:20 - 10:27 | Abstract presentation: Phase II study of pembrolizumab and lenvatinib in advanced well-differentiated neuroendocrine tumors
|
| Jonathan Strosberg, USA |
| 10:27 - 10:30 | Discussion
|
Session 5B: Nurses & Dietitians Symposium
Time: Friday 09:00 - 10:00
Room: Hall F
Moderators:
Yasmin Chotai de Lima, GBR / Wanda Geilvoet, NED
| 09:00 - 09:05 | Welcome and update on nurses and dietitian group
|
| Wendy Martin, GBR |
| 09:05 - 09:20 | Assessing the nutritional status of patients with NEN’s
|
| Erin Laing, AUS |
| 09:20 - 09:35 | Sarcopenia in patients with NEN’s
|
| Dominique Clement, GBR |
| 09:35 - 09:55 | Case study – Managing a patient with complex nutritional needs (interactive session)
|
| Mette Borre, DEN / Deborah Pitfield, GBR |
Panel: Erin Laing, AUS / Dominique Clement, GBR / Wendy Martin, GBR
| 09:55 - 10:00 | Thank you and closing comments
|
| Wendy Martin, GBR |
Session 5C: Clinical abstracts
Time: Friday 10:00 - 10:30
Room: Hall F
Moderators:
Hans Hofland, NED / Nicholas Reed, GBR
| 10:00 - 10:07 | Are hemicolectomies still indicated in patients with neuroendocrine tumours of the appendix 1-2cm? A retrospective Europe-wide cohort study
|
| Cédric Nesti, SUI |
| 10:07 - 10:10 | Discussion
|
| 10:10 - 10:17 | No multiple endocrine neoplasia type 1 (MEN1) Patient died from pancreaticoduodenal neuroendocrine tumor – Results from long-term follow-up of the Uppsala model of early diagnosis and treatment
|
| Duska Bajic, SWE |
| 10:17 - 10:20 | Discussion
|
| 10:20 - 10:27 | Endoscopic ultrasound-guided radiofrequency ablation versus surgical resection for the treatment of pancreatic insulinoma – A multicenter propensity score-matched study
|
| Stefano Francesco Crinò, ITA |
| 10:27 - 10:30 | Discussion
|
COFFEE BREAK
Time: Friday 10:30 - 11:00
Room: Entrance Hall
Session 6A: Colorectal NET
Time: Friday 11:00 - 12:10
Room: Hall E
Moderators:
John Ramage, GBR / Thomas Walter, FRA
| 11:00 - 11:10 | Epidemiology and health economics: Comparison of incidences around the world
|
| Côme Lepage, FRA |
| 11:10 - 11:15 | Discussion
|
| 11:15 - 11:30 | Colo-rectal NET: Surgery vs endoscopy
|
| Els Nieveen van Dijkum, NED |
| 11:30 - 11:35 | Discussion
|
| 11:35 - 11:45 | What to do after R1 endoscopic rectal resection?
|
| Raj Srirajaskanthan, GBR |
| 11:45 - 11:50 | Discussion
|
| 11:50 - 11:57 | Abstract presentation: Outcome of endoscopic submucosal dissection for rectal neuroendocrine neoplasms – A multicentre study
|
| Alessandro Rimondi, ITA |
| 11:57 - 12:00 | Discussion
|
| 12:00 - 12:07 | Abstract presentation: Heterogeneity and potential therapeutic targets of rectal neuroendocrine tumors by single cell RNA-sequencing combined with spatial omics
|
| Qiyun Tang, CHN |
| 12:07 - 12:10 | Discussion
|
Session 6B: Basic and translational science abstracts
Time: Friday 11:00 - 12:10
Room: Hall F
Moderators:
Aurel Perren, SUI / Chrissie Thirlwell, GBR
| 11:00 - 11:07 | Wide molecular analysis of PanNET revealed that only MGMT promoter methylation seemed to correlate with Temozolomide response
|
| Ilaria Marinoni, SUI |
| 11:07 - 11:11 | Discussion
|
| 11:11 - 11:18 | Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
|
| Halfdan Sorbye, NOR |
| 11:18 - 11:23 | Discussion
|
| 11:23 - 11:31 | Predictive transcriptomic signature of response to axitinib in patients with advanced NETs included in the randomized, double-blind, placebo-controlled AXINET trial (GETNE 1107)
|
| Alberto Lens-Pardo, ESP |
| 11:31 - 11:35 | Discussion
|
| 11:35 - 11:42 | Determining the resistance to somatostatin analogues in pheochromocytomas and paragangliomas
|
| Víctor García Vioque, ESP |
| 11:42 - 11:47 | Discussion
|
| 11:47 - 11:54 | Mesenteric fibrosis in small intestinal neuroendocrine tumours (SI-NETs) – Steps towards understanding its pathogenesis
|
| Harry Hodgetts, GBR |
| 11:54 - 11:58 | Discussion
|
| 11:58 - 12:05 | Autologous ECM-composed scaffolds and zebrafish PDXs for individualized therangostics in rare neuroendocrine neoplasms
|
| Chiara Liverani, ITA |
| 12:05 - 12:10 | Discussion
|
LUNCH BREAK
Time: Friday 12:10 - 12:55
Room: Entrance Hall
Session 7: Abstracts and research highlights in 2022
Time: Friday 12:55 - 13:50
Room: Hall E
Moderators:
Eva Tiensuu Janson, SWE
| 12:55 - 13:25 | Medical review
|
| Nicholas Reed, GBR |
| 13:25 - 13:50 | Surgical review
|
| Stefano Partelli, ITA |
Awards Ceremony
Time: Friday 13:50 - 14:25
Room: Hall E
Closing comments
Time: Friday 14:25 - 14:30
Room: Hall E
Moderators:
Eva Tiensuu Janson, SWE